MDL Track
MDL 3004
S.D. Ill.
Paraquat products liability
6,509 pending
Agrochemical · claims linking paraquat herbicides to Parkinson's disease and neurological injury
Defendant
Syngenta Crop Protection, LLC
MDL / Track
MDL 3004
S.D. Ill.
Judge
Chief Judge Nancy J. Rosenstengel
Plaintiffs
~6,517 pending (6,509 per JPML March 2, 2026 report, plus 8 new filings tracked)
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
The paraquat MDL entered settlement administration in 2026 after Judge Nancy J. Rosenstengel approved a Qualified Settlement Fund in March 2026, canceling the April 2026 trial date and maintaining a discovery stay. In re: Paraquat Products Liability Litigation, MDL No. 3004 (S.D. Ill.), consolidated more than 6,600 federal cases as of June 2026 alleging Syngenta and Chevron failed to warn that occupational exposure to the herbicide causes Parkinson's disease. The litigation remains procedurally complicated: plaintiffs' appeal of Judge Rosenstengel's April 17, 2024 Daubert ruling excluding sole general-causation expert Dr. Martin Wells is pending before the Seventh Circuit but held in abeyance, while the court selected opt-out cases for limited discovery in June 2026 after adopting a special master's report.
Causation Theory
Plaintiffs' causation theory centers on paraquat's ability to generate reactive oxygen species and damage dopaminergic neurons, with the NIH-funded Agricultural Health Study finding paraquat applicators face 2.5 times the normal Parkinson's disease risk. The mechanism involves paraquat-induced alpha-synuclein protein clumping, a hallmark of Parkinson's pathology. Internal corporate documents obtained through EPA disclosure and U.S. litigation depositions indicate Syngenta's own rat studies showed paraquat caused Parkinson's-associated symptoms and that by 1958 the company had reason to assume the chemical could damage or kill brain cells.
Case Management Orders
Litigation status
MDL 3004 is in active settlement administration following Judge Nancy J. Rosenstengel's March 2026 approval of a Qualified Settlement Fund and cancellation of the April 6, 2026 bellwether trial. Amended Administrative Order No. 322 (Sept. 30, 2026) and a Media Access Agreement (Sept. 30, 2026) indicate ongoing procedural refinement. Case Management Order No. 25 imposes Lone Pine requirements on nonsettling plaintiffs, including mandatory special master meetings for opt-outs.
MDL Track
MDL 3004
S.D. Ill.
Paraquat products liability
6,509 pending
State Court Activity
Philadelphia state court hosted settled January 2026 bellwether; limited state court activity as federal settlement dominates
MDL 3004 Leadership
Plaintiff Leadership
Co-Lead Counsel
Co-Lead Counsel and MDL Plaintiffs' Liaison
Sarah Shoemake Doles
Levin, Papantonio, Rafferty, Proctor, Buchanan, O'Brien, Barr & Mougey, P.A.
contact@levinlaw.com(850) 435-7000Plaintiffs' Executive Committee (PEC) and State Court Liaison for Illinois
Plaintiffs' Executive Committee (PEC) and State Court Liaison for California
Plaintiffs' Executive Committee (PEC)
LaRuby May
Levin, Papantonio, Rafferty, Proctor, Buchanan, O'Brien, Barr & Mougey, P.A.
contact@levinlaw.com(850) 435-7000Geographic exposure
Approximately 8,100 total cases: 6,500 in MDL No. 3004 (S.D. Ill.), 1,600 in Pennsylvania state court, nearly 500 in California. EPA 2026 review underway; 13 states introduced 2026 legislation to ban or restrict paraquat, with bills active in eight states (IL, IA, MO, MN, NY, NJ, VT, PA).
MDL No. 3004 hub for paraquat-Parkinson's litigation. Nearly 6,500 cases consolidated before Judge Nancy J. Rosenstengel. No bellwether trials concluded as of February 2026. Plaintiff Harrison v. Syngenta filed August 2023 in Eastern Division (Case 3:23-cv-00801).
Sipcam Agro facility is the largest single emitter of paraquat in the U.S., releasing 81,667 pounds combined in 2023-2024 (47,000+ pounds in 2024 alone) as fugitive emissions. Wayne County Parkinson's mortality rate of 21.5 per 100,000 is nearly double the statewide rate of 12.2 and national average of 11.5. Hundreds of households, predominantly Black, within one mile of plant.
High-use zone for row-crop systems (soybeans, cotton) with aerial and ground application. Exposure risks for licensed applicators, farmworkers, equipment cleaners, and residents via drift. Tunica identified as site of additional paraquat storage facility.
Formulation and packaging facility in 'Cancer Alley' receiving paraquat concentrate via Port of New Orleans. Black residents in Iberville Parish have life expectancy of 69 years, below national average of 78.
State-court mass-tort program with approximately 1,600 cases pending as of February 2026. Active legislation to ban paraquat introduced 2026.
Syngenta subsidiary Adama facility reported 10 pounds of paraquat air emissions to EPA in 2020. Crisp County has paraquat facilities operated by Drexel Chemical and Helena Industries; Black residents have life expectancy of 66 years.
Hazardous waste facility reported releasing one pound of paraquat into air in 2023. Facility previously penalized for improper storage.
Site of Joe Harrison's cattle ranch exposure (1997-2022), central to Harrison v. Syngenta litigation. Rural residential exposure via application to vegetation.
Residential exposure via proximity to farm fields. Gorman v. Syngenta filed 2022 alleging Parkinson's from paraquat in drinking water.
Key defendants
Syngenta Crop Protection, LLC
Role: Manufacturer
Primary U.S. manufacturer and marketer of Gramoxone. SCOTUS declined cert in Nemeth (No. 24-1190) Oct. 2025, preserving Pennsylvania consent-by-registration jurisdiction. MDL 3004 (S.D. Ill.) stay extended to Jan. 2026; early Philadelphia bellwethers settled pre-trial Aug. and Oct. 2025.
Syngenta AG
Role: Parent Manufacturer
Swiss parent controlling global paraquat operations. High degree of control over U.S. subsidiary established in City of Greenville, 830 F. Supp. 2d 550 (S.D. Ill. 2011). Named in Canadian class actions (Ontario, B.C., Québec) alongside U.S. litigation.
Chevron U.S.A., Inc.
Role: Former Manufacturer/Distributor
Manufactured and sold Gramoxone under license 1964-1986. Philadelphia court denied removal/dismissal of 938 out-of-state plaintiffs July 2025, calling request 'daft.' Exposure claims pre-1986 remain viable; indemnity posture unclear.
| Defendant | Role | Intelligence Note |
|---|---|---|
| Syngenta Crop Protection, LLC | Manufacturer | Primary U.S. manufacturer and marketer of Gramoxone. SCOTUS declined cert in Nemeth (No. 24-1190) Oct. 2025, preserving Pennsylvania consent-by-registration jurisdiction. MDL 3004 (S.D. Ill.) stay extended to Jan. 2026; early Philadelphia bellwethers settled pre-trial Aug. and Oct. 2025. |
| Syngenta AG | Parent Manufacturer | Swiss parent controlling global paraquat operations. High degree of control over U.S. subsidiary established in City of Greenville, 830 F. Supp. 2d 550 (S.D. Ill. 2011). Named in Canadian class actions (Ontario, B.C., Québec) alongside U.S. litigation. |
| Chevron U.S.A., Inc. | Former Manufacturer/Distributor | Manufactured and sold Gramoxone under license 1964-1986. Philadelphia court denied removal/dismissal of 938 out-of-state plaintiffs July 2025, calling request 'daft.' Exposure claims pre-1986 remain viable; indemnity posture unclear. |
Timeline
MDL 3004 Formed in S.D. Ill.
Judicial Panel on Multidistrict Litigation consolidated 14 federal paraquat cases into In re: Paraquat Products Liability Litigation, MDL No. 3004, assigned to Chief Judge Nancy J. Rosenstengel in the Southern District of Illinois.
Syngenta Pays $187.5 Million Settlement
Syngenta resolved an earlier batch of Illinois paraquat cases for $187.5 million, before the MDL bellwether process began.
Judge Rosenstengel Rules on Motion to Dismiss
Chief Judge Rosenstengel granted in part and denied in part a defense motion to dismiss, narrowing some claims but allowing core allegations to proceed in MDL 3004.
Daubert Ruling Excludes Sole General Causation Expert
Judge Rosenstengel issued a 97-page opinion excluding Dr. Martin Wells, plaintiffs' sole general causation expert, under Federal Rule of Evidence 702, finding his methodology unreliable due to non-replicable study selection, 'methodological shapeshifting,' and lack of independent validation. Court dismissed four bellwether cases with prejudice same day. In re: Paraquat Products Liability Litigation, Doc. 5238 (S.D. Ill.).
Confidential Settlement Agreement Signed
Syngenta and Chevron signed a confidential settlement agreement aimed at resolving thousands of paraquat claims. Parties later formalized a Master Settlement Agreement.
Master Settlement Agreement Executed
Parties formalized a broader settlement agreement dated August 4, 2025, and hired settlement and lien negotiation administrators. Pretrial deadlines remained paused.
Philadelphia Bellwether Settles Eve of Trial
First Philadelphia Court of Common Pleas bellwether trial, Bill Mertens v. Syngenta, settled confidentially the night before opening statements. Syngenta has settled every paraquat case reaching trial eve; no paraquat Parkinson's case has gone to jury verdict.
Court Approves Qualified Settlement Fund
Judge Rosenstengel approved a Qualified Settlement Fund under IRC § 468B for MDL 3004 and canceled the April 6, 2026 bellwether trial 'in light of the pending settlement.' Discovery stays continued.
Special Master Appointed for Settlement Outreach
Court appointed Special Master Randi Ellis to provide plaintiffs with detailed information about settlement terms and individual options, responding to objections from firms excluded from original negotiations.
Syngenta Announces Global Paraquat Production End
Syngenta confirmed it will discontinue global paraquat production, a move plaintiffs' counsel highlighted as inconsistent with the company's continued defense of product safety.
Statute of limitations
MDL 3008 (In re Paraquat Products Liability Litigation), Judge Nancy J. Rosenstengel, S.D. Ill. Centralized 2,000+ cases. State law SOL applies to direct-filed actions; federal courts apply forum state's SOL under Erie. Consider tolling for fraudulent concealment where manufacturers allegedly suppressed causation evidence. EPA 2021 restrictions on paraquat use may support discovery-rule arguments for pre-2021 exposures.
⚠Kentucky
1 year from diagnosis
Rule: Ky. Rev. Stat. Ann. § 413.140(1)(a)
Discovery: Accrues at Parkinson's diagnosis, not exposure
Shortest SOL nationally; no pending revival statute
⚠Louisiana
1 year from diagnosis
Rule: La. Civ. Code Ann. art. 3492
Discovery: Accrues at diagnosis; contra non valentem may apply for latent disease
Contra non valentem doctrine limited; do not rely on for screening
⚠Tennessee
1 year from diagnosis
Rule: Tenn. Code Ann. § 28-3-104(a)(1)
Discovery: Accrues at diagnosis
Tennessee Savings Statute allows one refiling within 12 months if dismissed for reasons other than merits
California
2 years from diagnosis
Rule: Cal. Code Civ. Proc. § 335.1
Discovery: Discovery rule applies; accrues when plaintiff knows or should know of injury and its cause
Large plaintiff pool; consider venue shopping under Bristol-Myers Squibb Co. v. Superior Court, 582 U.S. 255 (2017)
Illinois
2 years from diagnosis
Rule: 735 Ill. Comp. Stat. 5/13-202
Discovery: Accrues at Parkinson's diagnosis
Active MDL 3008 (S.D. Ill.) with Judge Rosenstengel; consider state court parallel track
Florida
4 years from diagnosis
Rule: Fla. Stat. Ann. § 95.11(3)(a)
Discovery: Discovery rule applies; statute begins at diagnosis or when link reasonably discoverable
No caps on non-economic damages in product liability; favorable venue for agricultural workers
Missouri
5 years from diagnosis
Rule: Mo. Rev. Stat. § 516.120(4)
Discovery: Discovery rule applies; accrues at diagnosis
Longest SOL in Midwest; significant agricultural exposure history; consider venue in St. Louis City
Maine
6 years from diagnosis
Rule: 14 Me. Rev. Stat. Ann. § 752
Discovery: Discovery rule applies; longest SOL nationally
Remote plaintiff pool but maximum temporal flexibility for late-diagnosed cases
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| ⚠Kentucky | 1 year from diagnosis | Ky. Rev. Stat. Ann. § 413.140(1)(a) | Accrues at Parkinson's diagnosis, not exposure | Shortest SOL nationally; no pending revival statute |
| ⚠Louisiana | 1 year from diagnosis | La. Civ. Code Ann. art. 3492 | Accrues at diagnosis; contra non valentem may apply for latent disease | Contra non valentem doctrine limited; do not rely on for screening |
| ⚠Tennessee | 1 year from diagnosis | Tenn. Code Ann. § 28-3-104(a)(1) | Accrues at diagnosis | Tennessee Savings Statute allows one refiling within 12 months if dismissed for reasons other than merits |
| California | 2 years from diagnosis | Cal. Code Civ. Proc. § 335.1 | Discovery rule applies; accrues when plaintiff knows or should know of injury and its cause | Large plaintiff pool; consider venue shopping under Bristol-Myers Squibb Co. v. Superior Court, 582 U.S. 255 (2017) |
| Illinois | 2 years from diagnosis | 735 Ill. Comp. Stat. 5/13-202 | Accrues at Parkinson's diagnosis | Active MDL 3008 (S.D. Ill.) with Judge Rosenstengel; consider state court parallel track |
| Florida | 4 years from diagnosis | Fla. Stat. Ann. § 95.11(3)(a) | Discovery rule applies; statute begins at diagnosis or when link reasonably discoverable | No caps on non-economic damages in product liability; favorable venue for agricultural workers |
| Missouri | 5 years from diagnosis | Mo. Rev. Stat. § 516.120(4) | Discovery rule applies; accrues at diagnosis | Longest SOL in Midwest; significant agricultural exposure history; consider venue in St. Louis City |
| Maine | 6 years from diagnosis | 14 Me. Rev. Stat. Ann. § 752 | Discovery rule applies; longest SOL nationally | Remote plaintiff pool but maximum temporal flexibility for late-diagnosed cases |
Live intelligence
AI litigation brief
Paraquat remains settled / resolution phase with 119 current signals in the accepted feed.
Overview
MDL 3004 is in active settlement administration following Judge Nancy J. Rosenstengel's March 2026 approval of a Qualified Settlement Fund and cancellation of the April 6, 2026 bellwether trial. Amended Administrative Order No. 322 (Sept. 30, 2026) and a Media Access Agreement (Sept. 30, 2026) indicate ongoing procedural refinement. Case Management Order No. 25 imposes Lone Pine requirements on nonsettling plaintiffs, including mandatory special master meetings for opt-outs.
Key developments
Trajectory
Court filings and press coverage are both active in MDL 3004, pointing to sustained litigation pressure rather than a one-off headline cycle. 7 live sources are contributing current context.
Editorial intelligence
MDL 3004 should stay on the lead docket watch because it is the primary consolidation vehicle for Paraquat.
Generated Sep 30, 2026, 10:00 AM UTC
119 events detected
Google News (66)
Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US - theguardian.com
My husband has Parkinson’s. That’s why I started asking ques... - Chico News & Review
California just banned paraquat. The EPA should ban it nationwide - PIRG
Syngenta’s secrets – What the company didn't tell the EPA about its “blockbuster” paraquat pesticide - The New Lede
New documents reveal what a company didn’t disclose about weedkiller paraquat - The New Lede
My husband has Parkinson’s. That’s why I started asking questions about paraquat. - Capitol Weekly
I lost my nursing career to Parkinson’s — Pennsylvania can still reduce this risk for others - PennLive.com
Iowa senator pushes to ban paraquat - Axios
Columnist Dr. David Gottsegen: A portrayal of Parkinson’s and problem with paraquat - Daily Hampshire Gazette
Oregon lawmakers move to ban herbicide paraquat - youroregonnews.com
Federal inquiry into Paraquat weed killer welcomed by Parkinson’s advocates - nine.com.au
'Zero Testimony' of Exposure Sinks Paraquat Claims, May Thin MDL Docket - Law.com
California to phase out paraquat over health concerns. What does this mean for farmers? - capradio.org
Balkcom took $1,000 from Syngenta amid paraquat lawsuits - American Journal News
First Paraquat, Next Glyphosate? California bans widely-used toxin - Northcoast Environmental Center
First Paraquat, Next Glyphosphate? California bans widely-used toxin - Northcoast Environmental Center
RELEASE: Rep. Friedman Celebrates Official Phase-Out of Paraquat After Leading the Fight to Ban It - Representative Laura Friedman | (.gov)
Rep. Friedman Celebrates Official Phase-Out of Paraquat After Leading the Fight to Ban It - 2urbangirls.com
'We're Not Playing Games': Attorney Mark DiCello in Hot Seat Over Paraquat Clients - Law.com
Study finds age-related vulnerability to paraquat neurotoxicity in male rats - Bioengineer.org
Opinion: The Parkinson’s and paraquat connection — why Utah should join the lead to ban the herbicide - Deseret News
States seek to ban herbicide linked to Parkinson’s disease - Pluribus News
CA Department of Pesticide Regulation Allows Two-Year Paraquat Phaseout Despite Links to Parkinson's - Beyond Pesticides
California Starts Phasing Out a Heavily Sprayed Farm Weedkiller Long Studied for a Possible Parkinson's Link - Medical Daily
Nebraska still allows paraquat weed killer. An Iowa man with Parkinson’s wants it banned - Nebraska Public Media
Two Midwest states still allow paraquat weed killer. A man with Parkinson's wants it banned - Nebraska Public Media
Aug. 14 | Paraquat and Parkinson's, NU seeks $61M - Nebraska Public Media
California Begins Phasing Out Paraquat After Every Manufacturer Pulls the Weedkiller Rather Than Submit Health Data - Medical Daily
This Pesticide May Be Too Dangerous to Use. Farmers Say They Need It. - The New York Times
This Iowa senator living with Parkinson’s wants to ban paraquat weed killer, linked to the disease - Iowa Public Radio
California to End Use of Deadly, Parkinson’s-Linked Paraquat, Center for Biological Diversity Reports - Sierra Sun Times
Missouri and Illinois still allow paraquat weed killer. An Iowa man with Parkinson’s wants it banned - STLPR
Missouri and Kansas still allow paraquat weed killer. An Iowa man with Parkinson's wants it banned - KCUR
Insurers seek London court ruling to deny cover for Syngenta paraquat claims - theinsurer.com
California to phase out paraquat, a powerful weedkiller associated with serious health issues - Los Angeles Times
California phasing out herbicide linked to Parkinson’s disease - The New Lede
California to End Use of Deadly, Parkinson’s-Linked Paraquat - biologicaldiversity.org
Insurers Sue To Block Syngenta Parkinson's Suit Coverage - Law360
Insurers Sue Over Paying Herbicide Parkinson's Disease Suits - Law360
Meet the Bill: The Paraquat Prevention Act - Parkinson's Foundation
California announces voluntarily cancellation of common commercial pesticide - Sacramento Bee
Leadership Shakeup Hits Phila. Paraquat Litigation as Judge Names New Liaison Counsel - Law.com
Experts welcome proposed ban on deadly paraquat herbicide - Deccan Herald
The herbicide haunting a New York farm town - The Guardian
Residents of a North Country farm town want herbicide linked to brain disease banned - NCPR: North Country Public Radio
Residents of Washington Co. farm town want to ban herbicide linked to brain disease - NCPR: North Country Public Radio
Politics make it hard to regulate pesticide linked to Parkinson’s Disease - Miami Herald
Pa. Paraquat, Gov. Shapiro's Neighbors: A Midyear Report - Law360
Herbicide banned in 70 countries to be pulled from sale in Australia by chemical maker - The Guardian
Chemical manufacturer ends sales of controversial herbicide - abc.net.au
Judge decries ‘Hail Mary’ effort to boot Paraquat cases from Philadelphia - The Black Chronicle
Chemical manufacturer ends sales of controversial herbicide - ABC News & Headlines – Australian Broadcasting Corporation
i9 Investigation: Iowa farmers still use a pesticide banned worldwide. One lawmaker is fighting to change that. - KCRG
Government proposes complete ban on paraquat dichloride, cites health risks to humans, animals - The Economic Times
India weighs nationwide ban on paraquat as health and regulatory scrutiny intensifies - Indiatimes
India moves to ban paraquat dichloride herbicide amid health safety concerns - Indiatimes
Centre Imposes Immediate Nationwide Ban on Paraquat - Deccan Chronicle
Paraquat: Chemical banned around the world could be linked to incurable illness in Australia - Nine.com.au
Letter to the editor: Ban dangerous herbicide in Pa. - Pittsburgh Post-Gazette
Paraquat Dichloride and Carbosulfan May Get Banned in India - Global Agriculture
Judge Defends Decision Keeping Paraquat Cases In Philly - Law360
Michigan takes first step to outlaw highly toxic weed killer linked to Parkinson’s - MLive.com
Farmer's relief over paraquat ruling - Wimmera Mallee News
Judge pressures Parkinson’s patients over Syngenta paraquat settlement - The New Lede
EPA Plans Paraquat Roundtable as Safety Questions Grow - RFD-TV
Vermont becomes first US state to ban paraquat - MSN
Brain research • Gasparotto Denardin EL • PMID 42801931 • Journal Article.
Circulation • Qi XF • PMID 42770216 • Journal Article.
Ecotoxicology and environmental safety • Ye C • PMID 42748831 • Journal Article.
International journal of biological macromolecules • Wang Z • PMID 42744264 • Journal Article.
Frontiers in toxicology • Stephano F • PMID 42775384 • Journal Article.
The EPA announced it will host a roundtable to examine safety questions about paraquat herbicide, bringing together scientists, experts, and advocates to discuss solutions and alternatives—directly addressing the ongoing regulatory and safety concerns central to Parkinson's disease litigation.
EPA News Release regulatory on Jun 30 for Paraquat. Regulatory developments can change intake posture and motion practice quickly.
Paraquat Products Liability Litigation
PACER docket filed in JPML: The plaintiffs are suing Syngenta AG and Syngenta Crop Protection, LLC, along with other unnamed entities, alleging that their exposure to the herbicide Paraquat caused one plaintiff to develop Parkinson's disease. The lawsuit claims that the defendants knew about Paraquat's toxicity and its potenti
Plaintiff Assessment Questionnaire (PAQ) Referenced
The order references a Plaintiff's Assessment Questionnaire (PAQ), which is a discovery tool used to gather information from plaintiffs in the litigation.
Amended Administrative Order No. 322
This is an amended administrative order in MDL 3004, likely addressing case management procedures.
Media Access Agreement
This is a form for media representatives to agree to court media access policies and obtain credentials for electronic device use in courtrooms.
Attorney Instructions for Opening Paraquat Cases
Provides step-by-step instructions for attorneys to open new Paraquat cases in MDL 3004, including case type selection, party entry, and docketing procedures.
HIPAA Authorization for Medical Records
This is a HIPAA authorization form for releasing protected health information in connection with the Paraquat MDL, not a court order. It authorizes disclosure of medical records to specified law firms and litigation management.
Plaintiff's Assessment Questionnaire (PAQ)
This document is a Plaintiff's Assessment Questionnaire (PAQ) requiring plaintiffs to provide detailed personal and claim-related information under oath in the Paraquat MDL.
Amended Administrative Order No. 322
This is an amended administrative order in MDL 3004, likely addressing case management procedures.
HIPAA Authorization for Medical Records
This is a HIPAA authorization form for releasing protected health information in connection with the Paraquat MDL, not a court order. It authorizes disclosure of medical records to specified law firms and litigation management.
Plaintiff's Assessment Questionnaire (PAQ)
This document is a Plaintiff's Assessment Questionnaire (PAQ) requiring plaintiffs to provide detailed personal and claim-related information under oath in the Paraquat MDL.
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
84Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Sep 30, 2026, 10:00 AM UTC
Next: —
Source Monitoring
PACER
PACER
Google News
PubMed
EPA
Event feed
119
events detected
AI Brief
Paraquat remains settled / resolution phase with 119 current signals in the accepted feed.
Overview
MDL 3004 is in active settlement administration following Judge Nancy J. Rosenstengel's March 2026 approval of a Qualified Settlement Fund and cancellation of the April 6, 2026 bellwether trial. Amended Administrative Order No. 322 (Sept. 30, 2026) and a Media Access Agreement (Sept. 30, 2026) indicate ongoing procedural refinement. Case Management Order No. 25 imposes Lone Pine requirements on nonsettling plaintiffs, including mandatory special master meetings for opt-outs.
Key developments
PACER court filing on Dec 31: Paraquat Products Liability Litigation. ‖ theguardian.com news on Sep 25: Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US - theguardian.com. ‖ EPA News Release regulatory on Jun 30: EPA to Host Roundtable on Paraquat This Summer. ‖ PubMed research on Sep 27: An açaí oil-loaded nanocapsule formulation attenuates short-term paraquat-associated behavioral, oxidative, and neurochemical alterations in Drosophila melanogaster..
Generated Sep 30, 2026, 10:00 AM UTC
Tracked MDLs
MDL 3004
S.D. Ill.
Paraquat products liability